EQUITY RESEARCH MEMO

Tegra Medical

Generated 5/11/2026

Executive Summary

Conviction (model self-assessment)65/100

Tegra Medical is a private contract manufacturer specializing in the production of complete finished medical devices and complex components. Founded in 2005 and headquartered in Franklin, Massachusetts, the company combines multiple manufacturing technologies to produce intricate devices that meet rigorous regulatory standards, including ISO 13485 and FDA QSR compliance. With facilities in Massachusetts, Mississippi, and Costa Rica, Tegra Medical offers a global footprint to serve medical device OEMs seeking reliable outsourcing partners. The company's expertise lies in bridging design and commercialization, enabling clients to bring their devices from concept to market efficiently. As a private entity, Tegra Medical is not publicly traded, but its steady growth and multi-site operations position it as a key player in the medical device contract manufacturing space.

Upcoming Catalysts (preview)

  • Q3 2026Costa Rica Facility Expansion70% success
  • TBDMajor New Contract with MedTech OEM50% success
  • Q4 2026FDA QSR Re-certification or Upgrade85% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)